Health, Fitness & Food

Blood grown in a laboratory has been transfused into humans for the first time in a landmark clinical trial. Future Publishing | Future Publishing | Getty Images LONDON — Blood grown in a laboratory has been transfused into humans for the first time in a landmark clinical trial that U.K. researchers say could significantly improve

Former U.S. Secretary of State Hillary Clinton listens as she’s introduced by Jodi Hicks, President and CEO of Planned Parenthood Affiliates of California and Co-Chair of the Yes on Prop 1 campaign, during a Planned Parenthood clinic in San Francisco, Calif., on Thursday, Oct. 13, 2022. Jane Tyska | Digital First Media | East Bay

The naturally occurring psychedelic compound psilocybin can significantly reduce symptoms of depression, according to data from the largest trial of its type ever conducted. David Buzzard – media-centre.ca / Getty Images LONDON — The naturally occurring psychedelic compound psilocybin can significantly reduce symptoms of depression, according to data from the largest trial of its type

Halfpoint Images | Moment | Getty Images It’s open enrollment season, the time each year when millions of American workers and retirees must choose a health plan, whether new or existing. But picking health insurance can be a dizzying venture. Health plans have many moving parts — which may not come into focus at first

Dr. Anthony Fauci, White House Chief Medical Advisor and Director of the NIAID, responds to questions from Sen. Rand Paul (R-KY) at a Senate Health, Education, Labor, and Pensions Committee hearing on Capitol Hill on January 11, 2022 in Washington, D.C. Greg Nash | Pool | Getty Images White House chief medical advisor Dr. Anthony

In this article PFE Follow your favorite stocksCREATE FREE ACCOUNT A health worker administers a dose of Pfizer covid-19 vaccine to a man at the Sanford Civic Center. With the emergence of the Omicron covid-19 variant in numerous countries, including the United States, the US Centers for Disease Control (CDC) encouraged all vaccinated adults to

Estee Lauder (EL) and other Club holdings with meaningful exposure to the Chinese economy bounced Friday, following news that BioNTech ‘s (BNTX) Covid vaccine will soon be available to foreign residents living in China. We’re cautiously optimistic about the vaccine development , which adds to hopes that Beijing will soften its restrictive pandemic policies after

A nurse administers a flu vaccination shot to a woman at a free clinic held at a local library on October 14, 2020 in Lakewood, California. Mario Tama | Getty Images The U.S. is facing the highest flu hospitalization rates in more than a decade with children and the elderly most at risk, according to

Four of our Club holdings — Costco Wholesale (COST), Amazon (AMZN), Humana (HUM) and Bausch Health (BHC) — were in the news Thursday. Here’s how we feel about the developments. Costco The news: Costco reported sales for the retail month of October after the closing bell Wednesday evening. In the four-week period, net sales increased 7.7%

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. It’s not too late to sell Quick mentions: QCOM, COST, HUM 1. It’s not too late to sell Stocks fell on Thursday, continuing Wednesday’s losses after the Federal Reserve reaffirmed

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Fed decision ahead Quick takes on Club earnings 1. Fed decision ahead Stocks edged down Wednesday ahead of the Federal Reserve’s decision on interest rate increases, set for this afternoon.

Club holding Humana (HUM) reported a mixed-but-solid third quarter before the opening bell Wednesday. Early optimism about 2023 also supported our bullish view on the health insurer’s stock. Revenue increased 9% year-over-year to $22.75 billion, slightly below estimates of $22.76 billion, and adjusted earnings-per-share increased 42% to $6.88, exceeding estimates of $6.28 per share. Aiding

Eli Lilly (LLY) CEO David Ricks on Tuesday expressed optimism around the drugmaker’s innovation pipeline Tuesday, a stance we share despite the Club holding’s cluttered quarterly report issued earlier in the day . “The underlying fundamentals of the business are really strong,” Ricks said in a CNBC interview with Jim Cramer. “Seventy percent of our

Johnson & Johnson ‘s (JNJ) $16.6 billion deal to buy heart pump maker Abiomed (ABMD) will bolster its pharmaceutical and medical device business ahead of J & J’s plans to separate its consumer division into a separate company. The Abiomed acquisition is set to close at the end of the first quarter of 2023. The

A woman receives a dose of a vaccine against the coronavirus disease (COVID-19) at a sport stadium during the coronavirus disease pandemic, in Vina del Mar, Chile, April 22, 2021. Rodrigo Garrido | Reuters Long Covid is more common among women than men, according to federal data. More than 17% of women have had long

Club holding Humana (HUM) got an upgrade on Wall Street on Wednesday, exactly one week before the health insurer reports earnings. Deutsche Bank took Humana to a buy rating from a hold, citing its “leading position in Medicare Advantage,” a key reason we own the company as a defensive play in this tough economic environment.

The new COVID-19 booster which includes protection for Omicron at AltaMed Health Services in South Gate on Thursday, October 6, 2022. Sarah Reingewirtz | MediaNews Group | Los Angeles Daily News via Getty Images Two studies are raising doubts about whether the new omicron BA.5 booster really will offer better protection against Covid than the

We’re exiting our position in AbbVie (ABBV), selling 300 shares at roughly $148.14 each. We’re also buying 75 shares of Starbucks (SBUX) at roughly $85.93 each. Following Friday’s trades, Jim’s Charitable Trust will no longer own a position in AbbVie and will own 750 shares of Starbucks, increasing its weighting in the portfolio to 2.28%

A pharmacist prepares to administer COVID-19 vaccine booster shots during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center on September 09, 2022 in Chicago, Illinois. The recently authorized booster vaccine protects against the original SARS-CoV-2 virus and the more recent omicron variants, BA.4 and BA.5. Scott Olson |

A rendering of COVID-19 new Omicron sub-variant BQ.1.1 Koto_feja | E+ | Getty Images Two omicron subvariants that are resistant to key antibody treatments are on the rise in the U.S., according to data from the Centers for Disease Control and Prevention. The subvariants BQ.1 and BQ.1.1 now represent 27% of infections in the U.S.,